BTG2 bridges PABPC1 RNA-binding domains and CAF1 deadenylase to control cell proliferation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 26912148.
- Also identified by DOI 10.1038/ncomms10811 and PMC identifier 4773420.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
While BTG2 plays an important role in cellular differentiation and cancer, its precise molecular function remains unclear. BTG2 interacts with CAF1 deadenylase through its APRO domain, a defining feature of BTG/Tob factors. Our previous experiments revealed that expression of BTG2 promoted mRNA poly(A) tail shortening through an undefined mechanism. Here we report that the APRO domain of BTG2 interacts directly with the first RRM domain of the poly(A)-binding protein PABPC1. Moreover, PABPC1 RRM and BTG2 APRO domains are sufficient to stimulate CAF1 deadenylase activity in vitro in the absence of other CCR4-NOT complex subunits. Our results unravel thus the mechanism by which BTG2 stimulates mRNA deadenylation, demonstrating its direct role in poly(A) tail length control. Importantly, we also show that the interaction of BTG2 with the first RRM domain of PABPC1 is required for BTG2 to control cell proliferation.
Medical subject headings
- Cell Proliferation
- Immediate-Early Proteins
- Poly(A)-Binding Protein I
- RNA, Messenger
- Transcription Factors
- Tumor Suppressor Proteins